SCHEMBL5804741

SCHEMBL5804741

CN(C(=O)CS(=O)(=O)NC(=O)OC(C)(C)C)C1CCCCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 4/20 0.41
CA14 Q9ULX7 4/20 0.41
ALDH1A1 P00352 4/20 0.41
CA1 P00915 2/20 0.41
CA7 P43166 2/20 0.41
CA2 P00918 1/20 0.41
EPHX1 P07099 1/20 0.41
GAA P10253 1/20 0.39
POLB P06746 1/20 0.39
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
LMNA P02545 1/20 0.38
MAPT P10636 1/20 0.38
TSHR P16473 1/20 0.38
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HSD17B10 Q99714 1/20 0.38
NPSR1 Q6W5P4 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
ATM Q13315 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3039993 0.80 EPHX1 (0.49) ALDH1A1EPHX1GAAKMT2AMEN1
SCHEMBL1951584 0.72 GAA (0.41) ALDH1A1CA1CA2EPHX1GAA
SCHEMBL2813531 0.72 HDAC4 (0.42) ALDH1A1EPHX1GAAKMT2ABTK
SCHEMBL2813537 0.72 HDAC4 (0.42) ALDH1A1EPHX1GAAKMT2ABTK
SCHEMBL4552317 0.72 HSD11B1 (0.44) ALDH1A1EPHX1GAAKMT2AMEN1
SCHEMBL31419036 0.71 GAA (0.45) CA12CA14CA1CA2EPHX1
SCHEMBL3039099 0.71 CTSS (0.42) ALDH1A1CA1CA7CA2EPHX1
SCHEMBL7129642 0.71 ALDH1A1 (0.59) ALDH1A1KMT2AMEN1LMNATSHR
SCHEMBL13943891 0.70 HSD11B1 (0.45) ALDH1A1EPHX1GAAKMT2AMEN1
SCHEMBL22403974 0.70 CA12 (0.50) CA12CA14CA1CA7CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1713822-A2 HCV NS-3 SERINE PROTEASE INHIBITORS Medivir Aktiebolag (SE) 2006-10-25 EP disclosed
WO-2005073216-A2 HCV NS-3 SERINE PROTEASE INHIBITORS MEDIVIR AB (SE) 2005-08-11 WO disclosed